Medicinal Cannabis Matters: Friday Roundup - 20 March 2026

Rethinking the Conversation Around Cannabis and Mental Health

A recent article from Leafie challenges the recent claims about cannabis and mental health, arguing that some narratives may oversimplify a far more complex clinical picture.

The article responds to commentary published in The Lancet, highlighting the need to distinguish between recreational use and carefully prescribed medicinal cannabis. In clinical settings, medicinal cannabis is prescribed with specific dosing and ongoing medical supervision, factors that significantly influence outcomes.

For patients, this distinction matters. Conversations around mental health and cannabis are becoming more balanced, with increasing recognition that, under specialist care, medicinal cannabis may have a role in managing conditions such as anxiety and treatment-resistant depression for some individuals.

Can Medicinal Cannabis Help Menopause?

Another article from Leafie explores how medicinal cannabis is being considered as a potential option for managing menopause-related symptoms.

Many women experience a combination of sleep disruption, anxiety, mood changes and chronic discomfort during menopause. The article highlights how medicinal cannabis may support some of these symptoms by interacting with the body’s endocannabinoid system, which plays a role in regulating mood, sleep and pain.

While research in this area is still developing, patient interest is increasing. As awareness grows, it is important that women have access to clear, evidence-based information and the opportunity to explore treatment options safely with qualified clinicians.

Spain Legalises Medicinal Cannabis

Internationally, Spain has taken a notable step by legalising medical cannabis, in what has been described as a historic development. The new framework introduces regulated access for patients, although strict rules remain around prescribing and distribution.

While each country approaches regulation differently, developments like this signal continued momentum across Europe. Expanding legal frameworks contribute to broader research opportunities, improved supply chains and increased acceptance of medicinal cannabis within healthcare systems.

For the UK, international progress often feeds into the wider conversation, supporting a gradual shift towards more informed, structured and patient-focused care.

This week’s stories highlight that the conversation around medicinal cannabis is becoming more detailed, more evidence-led and more centred on individual patient needs.

Whether it is improving understanding in mental health, opening up new discussions in women’s health, or expanding access internationally, the direction of travel is clear. Medicinal cannabis is increasingly being recognised as part of a wider, modern approach to healthcare.

If you are considering whether medicinal cannabis may be suitable for your condition, the first step is to check your eligibility. Medicann’s online eligibility checker takes just two minutes and provides a clear, confidential starting point before speaking with a clinician.

Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.